ArticleBMC pulmonary medicine2025
Gaps in access to pulmonary hypertension care and opportunities for improvement: a multi-site qualitative study.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Quality of Pulmonary Hypertension Care Within Expert PH Centers: Patient and Provider Perspectives From a Multi-Site Qualitative Study.Pulmonary circulation · 2026Article
- Clinical Updates in Pulmonary Hypertension.Reviews in cardiovascular medicine · 2026Review
- Provider networks for pulmonary hypertension in Massachusetts: implications for improving referrals to expert care.Annals of the American Thoracic Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPulmonary hypertension (PH) is a progressive disease leading to right heart failure and early mortality. Early recognition of the disease and timely initiation of PH-specific therapies for qualifying PH subgroups are crucial for improving patient outcomes. Yet delays in diagnosis and treatment of PH persist. We aimed to explore patient and provider perspectives on access to and timeliness of PH care across the patient's entire health journey from symptom onset through follow-up care.
methodsWe conducted a multi-site qualitative study at three expert PH centers in the United States. We interviewed 41 key informants including 21 patients and 20 providers (physicians, physician assistants, PH pharmacists, and PH nurses). Guided by a conceptual model of the care continuum adapted to PH, we analyzed transcripts using a directed content analysis with both deductive (based on our conceptual model) and inductive coding.
resultsWe found barriers to timely access to PH care along the entire care continuum from symptom onset through receiving longitudinal PH care. Geographic barriers to care, limited non-expert PH knowledge, dismissal of patient's symptoms by providers, limited PH expert availability, and inadequate insurance coverage of PH medications emerged as the most prominent barriers to PH care access. Participants offered clear and specific solutions to address these care gaps, including establishing telementoring models to improve non-expert PH knowledge, building relationships between PH experts and community providers to bolster referral networks, leveraging technology to mitigate geographic barriers, and building satellite sites to expand access to PH experts.
conclusionsPatients with PH experience significant barriers to receiving timely PH care along their entire health journey. Comprehensive transformations to PH care delivery and health policies are needed to mitigate delays and improve quality of care for patients living with this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.